Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber’s optic neuropathy and multiple sclerosis – a case report
Crossref DOI link: https://doi.org/10.1186/s12883-016-0720-2
Published Online: 2016-10-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Holmøy, Trygve http://orcid.org/0000-0002-2529-5664
Beiske, Antonie G.
Zarnovicky, Svetozar
Myro, Aija Zuleron
Røsjø, Egil
Kerty, Emilia
License valid from 2016-10-18